New firm based on SLU research

Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.

Medtech giant separates

Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.

SDS Life Science satsar på regulatorisk spetskompetens

Life science blir "death science" i nya Bond

I den senaste Bondfilmen, "No time to die", har filmskaparna tagit steget in i biologi och genforskning. Life science har aldrig varit dödligare...

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Danish biorefinery can save US billions

The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

Konkurrenskraft, cancervård och MDR – läs krönikörernas tankar om branschen

Nya tankegångar, åsikter och framtidsvisioner från profiler i branschen, tillika krönikörer i Life Science Sweden och vår systertidning Medtech Magazine. Här ha...

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

New study of toxins and heart disease

Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...

Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.